A study led by the University of Eastern Finland suggests that adolescents who engage in active school transport and leisure-time physical activity perform better at secondary school than their inactive peers.
Lilly, Novo’s bet on heart disease starts to take shape, and 2024 could be a pivotal year for their GLP-1s
Eli Lilly and Novo Nordisk are steadily — and somewhat quietly — preparing to build comprehensive cardiovascular franchises helmed by their lucrative treatments for diabetes